Skip to main content
BIOPHARMA CREDIT PLC logo

BIOPHARMA CREDIT PLC — Investor Relations & Filings

Ticker · BPCR ISIN · GB00BDGKMY29 LEI · 213800AV55PYXAS7SY24 IL Financial and insurance activities
Filings indexed 734 across all filing types
Latest filing 2025-03-24 Transaction in Own Shar…
Country GB United Kingdom
Listing IL BPCR

About BIOPHARMA CREDIT PLC

https://bpcruk.com/

BioPharma Credit PLC is a specialist investment trust that provides debt capital to the life sciences industry. The company's primary objective is to generate long-term, sustainable income for shareholders by investing in a diversified portfolio of interest-bearing debt assets. These investments are typically secured by royalties, revenue streams, and other cash flows derived from approved pharmaceutical products and healthcare technologies. This strategy offers investors exposure to the life sciences sector through debt instruments while providing financing to companies for growth and development.

Recent filings

Filing Released Lang Actions
Transaction in Own Shares
Transaction in Own Shares Classification · 100% confidence The document explicitly announces a 'TRANSACTION IN OWN SHARES' where BioPharma Credit PLC purchased a specific number of its ordinary shares into treasury on March 24, 2025. It details the volume, prices, and the resulting number of shares held in treasury and in issue. This directly corresponds to the definition of 'Transaction in Own Shares' (POS), which covers share repurchases or issuance by the company.
2025-03-24 English
Transaction in Own Shares
Transaction in Own Shares Classification · 100% confidence The document is an official announcement from BioPharma Credit PLC regarding the purchase of its own ordinary shares into treasury. It details the number of shares purchased, the price per share, and the resulting impact on the company's treasury holdings and total voting rights. This aligns perfectly with the definition of 'Transaction in Own Shares' (POS).
2025-03-21 English
Holding(s) in Company
Major Shareholding Notification Classification · 100% confidence The document is a 'TR-1: Standard form for notification of major holdings' filed by BioPharma Credit PLC. It details a change in voting rights held by Adage Capital Management L.P., crossing a regulatory threshold. This is a standard regulatory disclosure for major shareholding notifications, which corresponds to the 'Major Shareholding Notification' category.
2025-03-21 English
Net Asset Value(s) and Monthly Factsheet
Net Asset Value Classification · 100% confidence The document is a short announcement (under 5,000 characters) from BioPharma Credit PLC reporting the unaudited net asset value (NAV) per share as of February 28, 2025. While it contains NAV data, it is formatted as a standard RNS (Regulatory News Service) announcement. According to the classification rules, specifically the 'Menu vs Meal' rule, this is a direct update of the NAV figure rather than a full report, and it fits the specific category for Net Asset Value updates.
2025-03-21 English
STATEMENT RE OPTINOSE, INC.
Regulatory Filings Classification · 98% confidence The document is an RNS (Regulatory News Service) announcement from BioPharma Credit PLC regarding a third-party M&A transaction (Paratek acquiring OptiNose) and its impact on the company's existing loan investment in OptiNose. While it discusses an M&A event, it is not a formal merger agreement document itself, but rather a corporate update on how a market event affects the company's portfolio. Given the nature of the announcement as a regulatory disclosure via the London Stock Exchange, it fits best under the RNS category.
2025-03-21 English
Transaction in Own Shares
Transaction in Own Shares Classification · 100% confidence The document is an official announcement from BioPharma Credit PLC regarding the purchase of its own shares (share buyback) into treasury. It details the number of shares purchased, the price per share, and the resulting total number of voting rights. This aligns perfectly with the definition for 'Transaction in Own Shares' (POS).
2025-03-20 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.